In vitro skin permeation of paromomycin from topical formulations across normal and stripped hairless mouse skin

S.T.P. Pharma Sciences

Volumn 13, Issue 3, 2003, Pages 203-208

  Castro, G A ^a   Nascimento, D S ^a   Fernandes, A P ^a   Nunan, E A ^a   Ferreira, L A M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cutaneous leishmaniasis; O w cream; Paromomycin; Petrolatum ointment; Skin permeation; Topical treatment

Indexed keywords

CREMOPHOR; GLYCEROL STEARATE; HEXADECANOL; HYDROGENATED CASTOR OIL; HYDROXYETHYLCELLULOSE; LIQUID PARAFFIN; MACROGOL; MINERAL OIL; PAROMOMYCIN; PETROLATUM; PETROLEUM;

ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREAM; DRUG FORMULATION; DRUG POTENCY; DRUG SOLUBILITY; GEL; HYDROPHILICITY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; OINTMENT; SKIN LEISHMANIASIS; SKIN PERMEABILITY; STRATUM CORNEUM;

EID: 0042369037     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BARRAL-NETO M., MACHADO P., BARRAL A. - Human cutaneous leishmaniasis: recent advances in physiopathology and treatment. - Eur. J. Dermatol., 5, 104-113, 1995.
2. BERMAN J.D. - Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. - Clin. Infect. Dis., 24, 684-703, 1997.
3. EL-ON J., JACOBS G.P., WEINRAUCH L. - Topical chemotherapy of cutaneous leishmaniasis. - Parasitol. Today, 4, 76-81, 1988.
4. EL-ON J., MESSER G. - Leishmania major: antileishmanial activity of methylbenzethonium chloride. - Am. J. Trop. Med. Hyg., 35, 1110-16, 1986.
5. EL-ON J., HALEVY S., GRUNWALD M.H., WEINRAUCH L. - Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. - J. Am. Acad. Dermatol., 27, 227-231, 1992.
6. BRYCESON A. - Therapy in man. - In: The Leishmaniasis in Biology and Medicine, Peters W., Killick-Kendrick R. Eds., Academic Press, London, 1987, pp. 847-907.
7. NEAL R.A., MURPHY A.G., OLLIARO P., CROFT S.L. - Aminosidine ointments for the treatment experimental cutaneous leishmaniasis. - Trans. R. Soc. Trop. Med. Hyg., 88, 223-225, 1994.
8. GROGL M., SCHUSTER B.G., ELLIS W.Y., BERMAN J.D. - Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (aminosidine) and gentamicin. - J. Parasitol., 85, 354-359, 1999.
9. ASILIAN A., JALAYER J., WHITWORTH J.A.G., GHASEMI R.L., NILFOROOSHZADEH M., OLLIARO P.A. - A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. - Am. J. Trop. Med. Hyg., 53, 648-651, 1995.
10. GREVELINK S.A., LERNER E.A. - Leishmaniasis. - J. Am. Acad. Dermatol., 34, 257-272, 1996.
11. MOON K.C., WESTER R.C., MAIBACH H.I. - Diseased skin models in the hairless Guinea pig: in vivo percutaneous absorption. - Dermatologica, 180, 8-12, 1990.
12. BRONAUGH R.L., STEWART R.F. - Methods for in vitro percutaneous absorption sudies. V. Permeation through damaged skin. - J. Pharm. Sci., 74, 1062-1066, 1985.
13. FLYNN G.L., DURRHEIM H., HIGUCHI W.I. - Permeation of hairless mouse skin. II. Membrane sectioning techniques and influence on alkanol permeabilities. - J. Pharm. Sci., 70, 52-56, 1981.
14. FERREIRA L.A.M., SEILLER M., GROSSIORD J.L., MARTY J.P., WEPIERRE J. - Vehicle influence on in vitro release of glucose: w/o, w/o/w and o/w systems compared. - J. Controlled Release, 33, 349-356, 1995.
15. BELLOLI C., CRESCENZO G., CARLI S., VILLA R., SONZOGNI, CARELLI G., ORMAS P. - Pharmacokinetics and dosing regimen of aminosidine in the dog. - Vet. Res. Commun., 20, 533-541, 1996.
16. EL-ON J., JACOBS G.P., WITZTUM E., GREENBLATT C.L. - Development of topical treatment by Leishmania major in experimental animals. - Antimicrob. Agents Chemother., 26, 745-51, 1984.
17. EL-ON J., GREENBLATT C.L. - An in vitro model for testing the effect of anti-leishmanial drugs of possible use in topical treatment. - Curr. Ther. Res., 33, 660-669, 1983.
18. NEAL R.A., ALLEN S., MCCOY N., OLLIARO P., CROFT S.L. - The sensitivity of Leishmania species to aminosidine. - J. Antimicrob. Chemother., 35, 577-584, 1995.
19. LALOR C.B., FLYNN G.L., WEINER N. - Formulation factors affecting release of drug from topical formulations. II. Effect of solubility on in vitro delivery of a series of n-alkyl p-aminobenzoates. - J. Pharm. Sci., 84, 673-676, 1995.
20. STONE H.H., KOLB L.D., PETTIT J., SMITH R.B. - The systemic absorption of antibiotic from the burned wound surface. - Am. Surg., 34, 639-642, 1968.
21. MAFUNE E., TAKAHASHI M., TAKASUGI N. - Effect of vehicles on percutaneous absorption of bucladesine (Dibutyryl Cyclic AMP) in normal and damaged rat skin. - Biol. Pharm. Bull., 18, 1539-1543, 1995.
22. MURAKAMI T., YOSHIOKA M., OKAMOTO I., YUMOTO R., HIGASHI Y., OKAHARA K., YATA N. - Effect of ointment bases on topical and transdermal delivery of salicylic acid in rats: evaluation by skin microdialysis. - J. Pharm. Pharmacol., 50, 55-61, 1998.
23. SOTO J., FUYA P., HERRERA R., BERMAN J. - Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. - Clin. Infect. Dis., 26, 56-58, 1998.
24. HOWES D., GUY R.H., HADGRAFT J., HEYLINGS J. et al. - Methods for assessing percutaneous absorption: the report and recommendations of ECVAM Workshop 13. - ATLA, 24, 81-106, 1996.
25. LU J., CWIK M., KANYOK T. - Determination of paromomycin in human plasma and urine by reversed-phase high-performance liquid chromatography using 2,4-dinitrofluorobenzene derivatization. - J. Chromatogr., 695, 329-335, 1997.
26. ROY S.D., HOU S-Y.E., WITHAM S.L., GLYNN G.L. - Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver and hairless mouse skin. - J. Pharm. Sci., 83, 1723-1728, 1994.
27. SATO K., SUGIBAYASHI K., MORIMOTO Y. - Species differences in percutaneous of nicorandil. - J. Pharm. Sci., 80, 104-107, 1991.